Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $4.1M | $4.9M | $47.5M | $80.8M | $123.8M | $191.1M |
| Cost of revenue | $0 | $0 | −$2.4M | −$1.5M | $20.6M | $138.8M | $75.0M | $266.8M |
| Gross profit | $0 | $0 | $6.4M | $6.4M | $26.9M | −$58.0M | $48.8M | −$75.7M |
| Gross margin | — | — | 157.4% | 129.7% | 56.6% | -71.8% | 39.4% | -39.6% |
| R&D | $0 | $0 | $86.4K | $0 | $2.8M | $4.6M | $3.8M | $3.2M |
| Operating income | −$29.3K | −$29.3K | −$1.5M | −$18.0M | −$84.6M | −$476.6M | −$43.5M | −$1.07B |
| EBITDA | −$29.3K | −$29.3K | −$1.8M | −$14.2M | −$78.7M | −$476.6M | −$35.8M | −$257.6M |
| Net income | −$29.3K | −$29.3K | −$12.4M | −$23.3M | −$81.6M | −$546.5M | −$114.8M | −$1.07B |
| Net margin | — | — | -303.1% | -473.2% | -171.6% | -676.5% | -92.7% | -561.8% |
| EPS (diluted) | -0.00 | -0.92 | -11.88 | -9.75 | -21.47 | -63.43 | -12.62 | -38.68 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds HEXO.
No tracked institution reports a position in HEXO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-12-19 | 1-for-14reverse |
| 2020-12-23 | 1-for-4reverse |
No one on the platform has traded HEXO yet.
| $30M |
| — |
| LIANYLianBio | $0.12 | -28.13% | $13M | — |
| MRNSMarinus Pharmaceuticals, Inc. | $0.55 | +0.00% | $30M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$HEXO wow what a crap stock. I am glad i got out of this in 2021. How many reverse splits?
View on StockTwits ↗$HEXO Market’s shaping up well today, stay focused, not emotional. Trade the plan, not the hype. @MelissaGeorge3
View on StockTwits ↗$HEXO Things are looking good today! Just a friendly reminder to prioritize discipline over emotion and focus on the process rather than the outcome. Let’s trade wisely and aim to finish in the green! Keep an eye on the market trends and opportunities, stay informed!🚀
View on StockTwits ↗$HEXO Success doesn’t happen overnight; it’s all about taking small steps! Stay steady and keep up your efforts. You’ve got this!
View on StockTwits ↗$APHA $HEXO $TLRY Fact check from historic peaks
View on StockTwits ↗$HEXO Today’s setup looks strong. Stay disciplined. Focus on the process. Expect positive outcomes. Keep sharp and aim for success!
View on StockTwits ↗$HEXO The beautiful consolidation in that channel signals an exciting opportunity for the next leg up in August!
View on StockTwits ↗$APHA $HEXO $TLRY Good morning, reiterating
View on StockTwits ↗$TLRY $HEXO $APHA Tilray alone peak market cap (pre-M&A, July 2018): $21B USD Total M&A spend (2018–2023): $1.97B USD (excluding Aphria merger valuation $ 5 Bill ) Peak Value of Hexo Corp stood at ~ 1.7 Billion $ Tell me why this can’t go 15 USD a share with 1.1 Billion float ? Project 420 @ 15 USD a Share
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.